| ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00387608) | National Institutes of Health Clinical Center (CC) | 2006-06-01 |
| Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases (NCT00376922) | Wake Forest University Health Sciences | 2006-06-01 |
| Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer (NCT00827099) | Northside Hospital, Inc. | 2006-06-01 |
| Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia (NCT00898092) | Alliance for Clinical Trials in Oncology | 2006-05-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis (NCT00132015) | National Institutes of Health Clinical Center (CC) | 2006-05-01 |
| VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia (NCT00354276) | Vion Pharmaceuticals | 2006-05-01 |
| Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00085449) | Alliance for Clinical Trials in Oncology | 2006-05-01 |
| Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies (NCT00477035) | Sally Arai | 2006-05-01 |
| Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia (NCT00896766) | Children's Oncology Group | 2006-05-01 |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT00402558) | M.D. Anderson Cancer Center | 2006-05-01 |
| Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes (NCT00352001) | Mikkael Sekeres MD | 2006-05-01 |
| Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324) | OHSU Knight Cancer Institute | 2006-05-01 |
| Children's Resiliency, Adjustment, and Coping (NCT00489632) | M.D. Anderson Cancer Center | 2006-04-01 |
| Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) (NCT00525746) | M.D. Anderson Cancer Center | 2006-03-31 |
| Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia (NCT00306202) | Bristol-Myers Squibb | 2006-03-31 |
| Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia (NCT00900380) | ECOG-ACRIN Cancer Research Group | 2006-03-28 |
| DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia (NCT00897936) | ECOG-ACRIN Cancer Research Group | 2006-03-23 |
| Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies (NCT00943592) | University of Chicago | 2006-03-01 |
| Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer (NCT00346359) | Fred Hutchinson Cancer Center | 2006-03-01 |
| A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy (NCT00597519) | Memorial Sloan Kettering Cancer Center | 2006-03-01 |
| Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors (NCT00624962) | Vanderbilt University | 2006-03-01 |
| Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT00450944) | Albert Einstein College of Medicine | 2006-02-22 |
| Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. (NCT00354172) | Masonic Cancer Center, University of Minnesota | 2006-02-01 |
| Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant (NCT00281814) | The Cleveland Clinic | 2006-02-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation (NCT00281801) | Case Comprehensive Cancer Center | 2006-02-01 |
| Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia (NCT00499759) | UNC Lineberger Comprehensive Cancer Center | 2006-02-01 |
| Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia (NCT00321880) | Wake Forest University Health Sciences | 2006-02-01 |
| Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer (NCT00281879) | OHSU Knight Cancer Institute | 2006-02-01 |
| Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (NCT00698685) | University of Arizona | 2006-01-23 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer (NCT00661999) | Mayo Clinic | 2006-01-01 |
| 2 Arm Study of Clofarabine IV in MDS Patients (NCT00422032) | M.D. Anderson Cancer Center | 2006-01-01 |
| Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia (NCT00550992) | Dutch Childhood Oncology Group | 2006-01-01 |
| Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NCT00295932) | Memorial Sloan Kettering Cancer Center | 2005-12-13 |
| Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) (NCT00569010) | M.D. Anderson Cancer Center | 2005-12-01 |
| Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) (NCT00267059) | M.D. Anderson Cancer Center | 2005-12-01 |
| Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study (NCT00978731) | Bristol-Myers Squibb | 2005-12-01 |
| Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders (NCT00293410) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-11-01 |
| VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia (NCT00083187) | Vion Pharmaceuticals | 2005-11-01 |
| Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00290004) | Pharmacyclics LLC. | 2005-11-01 |
| Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia (NCT00357565) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease (NCT00719849) | Fred Hutchinson Cancer Center | 2005-11-01 |
| Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia (NCT00345826) | Jonsson Comprehensive Cancer Center | 2005-11-01 |
| Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen (NCT00448357) | UNC Lineberger Comprehensive Cancer Center | 2005-10-01 |
| Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia (NCT00245115) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-10-01 |
| Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00618501) | Asan Medical Center | 2005-10-01 |
| Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia (NCT00428077) | OHSU Knight Cancer Institute | 2005-10-01 |
| Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder (NCT00274820) | Case Comprehensive Cancer Center | 2005-10-01 |
| Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) (NCT00350818) | M.D. Anderson Cancer Center | 2005-10-01 |
| Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients (NCT00493181) | M.D. Anderson Cancer Center | 2005-10-01 |
| A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL (NCT00858117) | Northwestern University | 2005-09-26 |
| Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (NCT00598624) | IRCCS San Raffaele | 2005-09-01 |
| Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil (NCT00608517) | Vanderbilt-Ingram Cancer Center | 2005-09-01 |
| Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders (NCT00437086) | Mayo Clinic | 2005-09-01 |
| A Standardized Nursing Intervention Protocol for HCT Patients (NCT00951626) | City of Hope Medical Center | 2005-09-01 |
| Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants (NCT00606437) | Duke University | 2005-09-01 |
| AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders (NCT00547196) | City of Hope Medical Center | 2005-08-16 |
| Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients (NCT00382590) | M.D. Anderson Cancer Center | 2005-08-01 |
| Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer (NCT00255749) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia (NCT00262743) | Mayo Clinic | 2005-08-01 |
| Multimodal Intervention in Allogeneic Stem Cell Transplantation (NCT00427115) | Rigshospitalet, Denmark | 2005-08-01 |
| Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies (NCT00143559) | St. Jude Children's Research Hospital | 2005-08-01 |
| Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment (NCT00436618) | Mayo Clinic | 2005-08-01 |
| Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors (NCT00112619) | Pediatric Brain Tumor Consortium | 2005-08-01 |
| Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage (NCT00248443) | Assistance Publique - Hôpitaux de Paris | 2005-08-01 |
| Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases (NCT00309842) | Masonic Cancer Center, University of Minnesota | 2005-07-28 |
| VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders (NCT00304005) | Vion Pharmaceuticals | 2005-07-01 |
| Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer (NCT00349024) | Children's Cancer and Leukaemia Group | 2005-07-01 |
| Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia (NCT00427791) | M.D. Anderson Cancer Center | 2005-07-01 |
| Reduced Intensity Transplant Using Extracorporeal Photopheresis (NCT00179790) | Ann & Robert H Lurie Children's Hospital of Chicago | 2005-07-01 |
| A Phase II Study of Umbilical Cord Blood Transplantation (NCT00676806) | Tufts Medical Center | 2005-07-01 |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer (NCT00546377) | Memorial Sloan Kettering Cancer Center | 2005-07-01 |
| Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia (NCT00618696) | Masonic Cancer Center, University of Minnesota | 2005-07-01 |
| A Study to Evaluate PT-523 in Patients With Refractory Leukemia (NCT00129558) | Spectrum Pharmaceuticals, Inc | 2005-07-01 |
| Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease (NCT00392782) | Masonic Cancer Center, University of Minnesota | 2005-07-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia (NCT00133991) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-07-01 |
| Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease (NCT00462657) | St. Bartholomew's Hospital | 2005-07-01 |
| Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant (NCT00321932) | University of Minnesota | 2005-07-01 |
| Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies (NCT00672165) | Memorial Sloan Kettering Cancer Center | 2005-07-01 |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia (NCT00337246) | Cancer Research UK | 2005-07-01 |
| Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia (NCT00265915) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-07-01 |
| Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer (NCT00611351) | University of Nebraska | 2005-06-07 |
| Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT00253513) | OHSU Knight Cancer Institute | 2005-06-01 |
| Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer (NCT00295880) | Masonic Cancer Center, University of Minnesota | 2005-06-01 |
| Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant (NCT00305682) | Masonic Cancer Center, University of Minnesota | 2005-06-01 |
| BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma (NCT00126646) | MedImmune LLC | 2005-06-01 |
| IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome (NCT00469144) | M.D. Anderson Cancer Center | 2005-06-01 |
| Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00245037) | OHSU Knight Cancer Institute | 2005-06-01 |
| Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant (NCT00376480) | Dana-Farber Cancer Institute | 2005-06-01 |
| CFAR Study in Patients With Chronic Lymphocytic Leukemia (NCT00525603) | M.D. Anderson Cancer Center | 2005-06-01 |
| Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases (NCT00317785) | Fred Hutchinson Cancer Center | 2005-05-01 |
| Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT00541034) | Memorial Sloan Kettering Cancer Center | 2005-05-01 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer (NCT00818961) | Northside Hospital, Inc. | 2005-05-01 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain (NCT00666211) | Vanderbilt-Ingram Cancer Center | 2005-05-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia (NCT00295997) | University of California, San Francisco | 2005-05-01 |
| Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders (NCT00114257) | National Cancer Institute (NCI) | 2005-05-01 |
| Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath (NCT00578942) | David Rizzieri, MD | 2005-05-01 |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission (NCT00454168) | The Vaccine Company | 2005-05-01 |
| Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL (NCT00074282) | Eastern Cooperative Oncology Group | 2005-04-14 |